Cancer
Malignant Cervical Neoplasm
CI-CAN-00007992Explore in graph →
Top-level506 active trials4 approved drugs14 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00007992Explore in graph →
Clinical trials
1,994 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (181)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03570593 | Removal of Urinary Catheter After Radical Surgery | completed | N/A | 95 | Barretos Cancer HospitalOTHER | 0 | Jun 27, 2018 | clinicaltrials |
| NCT00790569 | Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking | completed | N/A | 315 | Butler HospitalOTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT01764802 |
| Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer |
| completed |
| Phase 2 |
| 100 |
| Ohio State University Comprehensive Cancer CenterOTHER |
| 1 |
| May 30, 2018 |
| clinicaltrials |
| NCT00075569 | SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia | completed | Phase 2 | 64 | Albert Einstein College of MedicineOTHER | 1 | May 21, 2018 | clinicaltrials |
| NCT03141463 | Vvax001 Cancer Vaccine in (Pre) Malignant Cervical Lesions | completed | Phase 1 | 12 | University Medical Center GroningenOTHER | 1 | May 3, 2018 | clinicaltrials |
| NCT01613430 | Evaluating Coaches of Older Adults for Cancer Care and Health Behaviors(COACH) | completed | N/A | 1,106 | Johns Hopkins Bloomberg School of Public HealthOTHER | 1 | Apr 26, 2018 | clinicaltrials |
| NCT01080521 | Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy | completed | — | 247 | Gynecologic Oncology GroupNETWORK | 1 | Apr 12, 2018 | clinicaltrials |
| NCT01098630 | Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer | completed | — | 778 | Gynecologic Oncology GroupNETWORK | 1 | Apr 12, 2018 | clinicaltrials |
| NCT00746018 | Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy | completed | N/A | 39 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT03337269 | Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake | completed | N/A | 256 | University of PennsylvaniaOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT01440998 | Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Apr 5, 2018 | clinicaltrials |
| NCT00369122 | Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 2 | Mar 20, 2018 | clinicaltrials |
| NCT03071848 | A Study to Evaluate Safety and Effectiveness of Bevacizumab in Combination With Paclitaxel and Cisplatin/Carboplatin or Toptecan in Participants With Advanced Cervical Cancer | completed | — | 84 | Hoffmann-La RocheINDUSTRY | 1 | Mar 16, 2018 | clinicaltrials |
| NCT01642082 | Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 28 | Gynecologic Oncology GroupNETWORK | 1 | Mar 13, 2018 | clinicaltrials |
| NCT01585428 | Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers | completed | Phase 2 | 29 | National Cancer Institute (NCI)NIH | 1 | Mar 7, 2018 | clinicaltrials |
| NCT02524756 | Feasibility and Functional Outcome of Laparoscopic Nerve Sparing Radical Hysterectomy | completed | N/A | 46 | Osama Mohammad Ali ElDamshetyOTHER | 2 | Mar 6, 2018 | clinicaltrials |
| NCT02512835 | Understanding the Value of Community Vital Signs in Primary Care | completed | — | 120 | Virginia Commonwealth UniversityOTHER | 1 | Feb 28, 2018 | clinicaltrials |
| NCT01210222 | Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer | completed | Phase 2 | 35 | Gynecologic Oncology GroupNETWORK | 1 | Feb 23, 2018 | clinicaltrials |
| NCT02949791 | HIPEC Using High Intra-abdominal Pressure(HIPEC-IAP) | completed | Phase 2 | 38 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Feb 23, 2018 | clinicaltrials |
| NCT00743626 | Pap Smear Research Study | completed | N/A | 1,712 | University Health Network, TorontoOTHER | 1 | Feb 22, 2018 | clinicaltrials |
| NCT03384511 | The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. | completed | Phase 4 | 38 | Shandong Cancer Hospital and InstituteOTHER | 1 | Feb 20, 2018 | clinicaltrials |
| NCT02460237 | HPV Self-Test Intervention in Ohio Appalachia | completed | N/A | 103 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Feb 8, 2018 | clinicaltrials |
| NCT00257816 | Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma | completed | Phase 2 | 12 | University of California, IrvineOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT02680613 | Pilot Study of a Mobile Health Approach to Reduce Barriers to Cervical Cancer Screening in Tanzania(KCCPAS) | completed | N/A | 851 | Queen's UniversityOTHER | 1 | Jan 29, 2018 | clinicaltrials |
| NCT00193752 | Para-Aortic Lymph Nodal Staging & Evaluation of Treatment Outcome by 18F FDG-PET in Advanced Cancer Cervix | completed | — | 100 | Tata Memorial HospitalOTHER_GOV | 1 | Jan 23, 2018 | clinicaltrials |
| NCT00041093 | Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer | completed | Phase 2 | 27 | Gynecologic Oncology GroupNETWORK | 1 | Jan 10, 2018 | clinicaltrials |
| NCT00691301 | Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | completed | Phase 2 | 55 | Gynecologic Oncology GroupNETWORK | 1 | Jan 9, 2018 | clinicaltrials |
| NCT01276730 | Advanced Cervical Cancer Trial in India | completed | Phase 2 | 209 | University of LouisvilleOTHER | 1 | Dec 29, 2017 | clinicaltrials |
| NCT00381888 | Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer | completed | Phase 2 | 44 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT00610740 | CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer | completed | Phase 2 | 18 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT02531997 | A Mind-body Intervention to Improve Body and/or Self Image | completed | N/A | 97 | University of MichiganOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT00888173 | Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 45 | Gynecologic Oncology GroupNETWORK | 1 | Dec 6, 2017 | clinicaltrials |
| NCT00287911 | Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer | completed | Phase 1 | 18 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 2, 2017 | clinicaltrials |
| NCT00512551 | DNA Array Analysis of Patients With Cervical Cancer | completed | — | 18 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 30, 2017 | clinicaltrials |
| NCT00287885 | Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer | completed | Phase 1 | 18 | Masonic Cancer Center, University of MinnesotaOTHER | 0 | Nov 29, 2017 | clinicaltrials |
| NCT01582906 | A Survivorship Care Plan for Gynaecological Cancer Patients | completed | — | 150 | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 24, 2017 | clinicaltrials |
| NCT00941070 | Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer | completed | Phase 2 | 26 | National Cancer Institute (NCI)NIH | 1 | Nov 17, 2017 | clinicaltrials |
| NCT00666978 | Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking | completed | Phase 4 | 540 | Lisa Sanderson Cox, PhDOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT01225887 | Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 37 | Gynecologic Oncology GroupNETWORK | 1 | Oct 9, 2017 | clinicaltrials |
| NCT00081263 | Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia | completed | Phase 2 | 130 | Gynecologic Oncology GroupNETWORK | 1 | Sep 15, 2017 | clinicaltrials |
| NCT00508703 | Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy | completed | — | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 12, 2017 | clinicaltrials |
| NCT02280811 | T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers | completed | Phase 1 / Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Sep 6, 2017 | clinicaltrials |
| NCT00039442 | Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer | completed | Phase 2 | 21 | Gynecologic Oncology GroupNETWORK | 1 | Aug 24, 2017 | clinicaltrials |
| NCT00460356 | Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes | completed | — | 159 | Gynecologic Oncology GroupNETWORK | 1 | Aug 24, 2017 | clinicaltrials |
| NCT00017004 | Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia | completed | Phase 3 | 114 | Gynecologic Oncology GroupNETWORK | 1 | Aug 9, 2017 | clinicaltrials |
| NCT03243825 | Comparative Study of Different Neoadjuvant Therapies Before Radical Hysterectomy in Stage Ib2-IIa2 Cervical Cancer | completed | N/A | 120 | Chinese Academy of Medical SciencesOTHER | 1 | Aug 9, 2017 | clinicaltrials |
| NCT02046265 | Clinic-based Intervention to Promote Cervical Cancer Prevention Behaviors(StepUp) | completed | N/A | 60 | University of PennsylvaniaOTHER | 1 | Aug 3, 2017 | clinicaltrials |
| NCT02125344 | A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) | completed | Phase 3 | 961 | GBG Forschungs GmbHOTHER | 1 | Jul 13, 2017 | clinicaltrials |
| NCT02465892 | Pillars4Life Trial(Pillars4Life) | completed | N/A | 284 | Duke UniversityOTHER | 1 | Jul 2, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Jun 27, 2018source: clinicaltrials